Notably, the Hippo pathway plays oncogenic roles in several types of human cancers, such as estrogen receptor-positive breast cancer53–55, hematologic malignancies (e.g., lymphomas)56, prostate cancer57, and small cell lung cancer58. Here, ESR1 is linked to lymphoma.